⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Global PCSK9 Inhibitor Market Size, Share, Trends, Competitive Landscape, and Forecast, 2026 to 2034 | 18.3% CAGR Driven by Long-Acting siRNA Therapies and Asia-Pacific Expansion
globenewswire.com
AMGN
NVS
REGN
SNY
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
prnewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
NYC & Global Walk - 2026 FINAL Walk with Us to Cure Lupus Returns to New York City and Around the World on October 24
prnewswire.com
GILD
NVS
Global Nuclear Medicine (Radiopharmaceuticals) Market Size, Trends, and Forecast, 2026-2034 | Market to Reach USD 24.15 Billion as Theranostics and PET/SPECT Adoption Accelerate
globenewswire.com
LNTH
CAH
GEHC
NVS
MRK
Australia Drug Delivery Devices Market Size and Forecast to 2035 - Analysis by Product, Application, and End-user | Smart Devices and Home Care Drive 14% CAGR to USD 11.25 Billion
globenewswire.com
BDX
NVS
GSK
TEVA
ABBV
NVO
JNJ
SNY
VTRS
PFE
U.S. Pain Management Therapeutics Market Report 2026-2034 | Non-Opioid Therapies and Devices Drive Growth to US$ 38.66 Billion at 3.64% CAGR
globenewswire.com
LLY
PFE
GSK
NVS
MRK
ABT
JNJ
BAX
India Generic Drug Manufacturing Market Size, Share, Growth and Forecast 2025-2034 | Patent Expirations, Export Demand and Specialty Generics Drive a USD 46.76 Billion Opportunity
globenewswire.com
NVS
TEVA
SUN
VTRS
FSK
GILD
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
globenewswire.com
NVS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS